#2 - Medtronic (NYSE:MDT)
Medtronic (NYSE:MDT) is both a health care company and a technology company. While that does make the company’s stock volatile, it also means that investors should expect stable, consistent demand for its products.
Medtronic’s goal is to be a leader in robotic surgery and surgery training solutions. To this end, the company bought Mazor Robotics a company out of Israel that provided robotic-assisted surgery (RAS) systems. Digital surgery will usher artificial intelligence (AI) into the surgery realm. But aside from this catalyst, there are other reasons to own MDT stock. They have a trailing free cash flow of over $6 billion, which means they have plenty of cash to deploy into research and development. Even with that said, the company has a deep pipeline of products and is expanding its reach beyond the United States. And the company is a dividend aristocrat, meaning that it has increased its dividend every year for at least 25 years.
About Medtronic
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.
Read More - Current Price
- $81.69
- Consensus Rating
- Hold
- Ratings Breakdown
- 5 Buy Ratings, 4 Hold Ratings, 1 Sell Ratings.
- Consensus Price Target
- $94.91 (16.2% Upside)
